Recent weeks have seen two significant developments with respect to federal and state laws regulating financial interactions between pharmaceutical and medical device companies and health care providers: (1) the Centers for Medicare and Medicaid Services (“CMS”) submitted a draft of the final regulations implementing the so-called Federal Sunshine Law (42 U.S.C. § 1320a-7h) for the government clearance process that is a mandatory prerequisite for promulgation; and (2) the Massachusetts Department of Public Health (“DPH”) approved final regulations (105 C.M.R. § 970.000) implementing statutory revisions to the Massachusetts Marketing Code of Conduct.
Register now for your free, tailored, daily legal newsfeed service.
Questions? Please contact email@example.comRegister
Update on federal and state developments: regulation of financial interactions between health care providers and pharmaceutical and medical device companies
To view this article you need a PDF viewer such as Adobe Reader.
Popular articles from this firm
Related topic hubs
"I think it is a great service, continue the good work."